BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23241021)

  • 1. Poikilodermatous mycosis fungoides with a CD8+ CD56+ immunophenotype: a case report and literature review.
    Shiomi T; Monobe Y; Kuwabara C; Hayashi H; Yamamoto T; Sadahira Y
    J Cutan Pathol; 2013 Mar; 40(3):317-20. PubMed ID: 23241021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4+, CD56+ mycosis fungoides: case report and review of the literature.
    Horst BA; Kasper R; LeBoit PE
    Am J Dermatopathol; 2009 Feb; 31(1):74-6. PubMed ID: 19155730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycosis fungoides with a CD56+ immunophenotype.
    Wain EM; Orchard GE; Mayou S; Atherton DJ; Misch KJ; Russell-Jones R
    J Am Acad Dermatol; 2005 Jul; 53(1):158-63. PubMed ID: 15965442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides.
    Hodak E; David M; Maron L; Aviram A; Kaganovsky E; Feinmesser M
    J Am Acad Dermatol; 2006 Aug; 55(2):276-84. PubMed ID: 16844512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-positive CD4/CD8 mycosis fungoides: a rarely reported immunohistochemical profile.
    Tournier E; Laurent C; Thomas M; Meyer N; Viraben R; Brousset P; Lamant L
    J Cutan Pathol; 2014 Jan; 41(1):58-62. PubMed ID: 24134789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous involvement by colonic extranodal NK/T-cell lymphoma mimicking mycosis fungoides: a case report*.
    Sitthinamsuwan P; Pongpruttipan T; Bunyaratavej S; Karoopongse E; Kummalue T; Sukpanichnant S
    J Cutan Pathol; 2011 Dec; 38(12):1004-8. PubMed ID: 21883363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8-positive granulomatous mycosis fungoides: a case report with review of the literature.
    Ishida M; Hotta M; Takikita-Suzuki M; Kojima F; Okabe H
    J Cutan Pathol; 2010 Oct; 37(10):1072-6. PubMed ID: 20579213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poikilodermatous mycosis fungoides.
    Bloom B; Marchbein S; Fischer M; Kamino H; Patel R; Latkowski JA
    Dermatol Online J; 2012 Dec; 18(12):4. PubMed ID: 23286794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood mycosis fungoides with a CD8+ CD56+ cytotoxic immunophenotype.
    Poppe H; Kerstan A; Böckers M; Goebeler M; Geissinger E; Rosenwald A; Hamm H
    J Cutan Pathol; 2015 Apr; 42(4):258-64. PubMed ID: 25442255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and course of CD8+ cytotoxic variant of mycosis fungoides: a case series of seven patients.
    Nikolaou VA; Papadavid E; Katsambas A; Stratigos AJ; Marinos L; Anagnostou D; Antoniou C
    Br J Dermatol; 2009 Oct; 161(4):826-30. PubMed ID: 19558552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease.
    Vermeer MH; Geelen FA; Kummer JA; Meijer CJ; Willemze R
    Am J Pathol; 1999 Apr; 154(4):1203-10. PubMed ID: 10233858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile mycosis fungoides treated with bexarotene and PUVA.
    Rodríguez-Vázquez M; García-Arpa M; González-García J
    Int J Dermatol; 2007 Jan; 46(1):99-102. PubMed ID: 17214731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric CD8⁺CD56⁺ non-poikilodermatous mycosis fungoides: case report and review of the literature.
    Kempf W; Kazakov DV; Broekaert SM; Metze D
    Am J Dermatopathol; 2014 Jul; 36(7):598-602. PubMed ID: 24698938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
    Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
    Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical analysis of mycosis fungoides on paraffin-embedded tissue sections.
    Izban KF; Hsi ED; Alkan S
    Mod Pathol; 1998 Oct; 11(10):978-82. PubMed ID: 9796726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous CD4+ CD56+ hematologic malignancies.
    Magro CM; Porcu P; Schaefer J; Erter JW; Furman RR; Shitabata PK; Crowson AN
    J Am Acad Dermatol; 2010 Aug; 63(2):292-308. PubMed ID: 20541283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double CD4/CD8-Positive, Nonpoikilodermic Mycosis Fungoides Expressing CD56 in a Young Man.
    Santonja C; Sánchez-García FJ; Rodríguez-Rodríguez RN; Manso R; Requena L; Gil-Mateo MDP; Rodríguez-Pinilla SM
    Am J Dermatopathol; 2022 Dec; 44(12):936-939. PubMed ID: 35925554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycosis fungoides with CD20 expression: report of two cases and review of the literature.
    Harms KL; Harms PW; Anderson T; Betz BL; Ross CW; Fullen DR; Hristov AC
    J Cutan Pathol; 2014 Jun; 41(6):494-503. PubMed ID: 24467775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Most CD8+ cells in skin lesions of CD3+ CD4+ mycosis fungoides are CD3+ T cells that lack CD11b, CD16, CD56, CD57, and human Hanukah factor mRNA.
    Wood GS; Dubiel C; Mueller C; Abel EA; Hoppe RT; Edinger A; Weissman I; Warnke RA
    Am J Pathol; 1991 Jun; 138(6):1545-52. PubMed ID: 1828937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric CD8+/CD56+ mycosis fungoides with cytotoxic marker expression: A variant with indolent course.
    Rovaris M; Colato C; Girolomoni G
    J Cutan Pathol; 2018 Oct; 45(10):782-785. PubMed ID: 29968317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.